NEW YORK, Nov. 1 (GenomeWeb News) - Agendia has registered its MammaPrint microarray test as a medical device with the Dutch Healthcare Inspectorate, the company said today. Both the microarray and the array production were registered.
Registering provides access to this and other free content.
Already have an account?Login Now.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.